Frontlight ResearchEarly access
Trial site
USC Keck School of Medicine
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Heart failure2 trials
- Hidradenitis suppurativa2 trials
- Brain aneurysm1 trial
- Coronary artery disease1 trial
- Lung cancer1 trial
- Spinal cord injury1 trial
- Phase
- Phase 34 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals2 trials
- University of Southern California2 trials
- Washington University School of Medicine2 trials
- Addario Lung Cancer Medical Institute1 trial
- Biogen1 trial
- and 6 more
Running trials
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Recruiting
Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Brain aneurysm1 recruiting
- Coronary artery disease1 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Terminated
Completed
Terminated
Withdrawn
Site data: ClinicalTrials.govUpdated 17 Nov 2026